Document is current
Any future updates will be listed below
-
Authors
-
Funding
Funding for this research was provided by:
Actelion Pharmaceuticals (Actelion Pharmaceuticals)
- License Information
-
More Information
Article History
Accepted: 20 November 2022
First Online: 3 December 2022
Declarations
:
: DMS has received honoraria paid to her research institute for educational presentations for BMS-Pfizer, Leo Pharma, Roche, Servier. DMS is supported by a Tier 2 Canada Research Chair in Anticoagulant Treatment of Cardiovascular Disease. JA is an advisor to Covis Pharmaceuticals. DF is employed by Covis Pharmaceuticals.
